Penumbra

Company Description

Penumbra, Inc. is a thrombectomy company focused on developing technologies for challenging medical conditions by removing blood clots. Its main businesses include developing, manufacturing, and marketing novel products for conditions such as ischemic stroke, venous thromboembolism, acute limb ischemia, and acute coronary syndrome. The company operates in the United States, Europe, Canada, and Australia. In the last fiscal year, the company had 4500 employees, a market cap of $9155 million, profits of $755 million, and revenue of $1195 million.

Analysis

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Penumbra are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Penumbra. The consolidated Growth Rank has a good rank of 77, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 77% of competitors in the same industry. The consolidated Safety Rank at 95 means that the company has a financing structure that is safer than 95% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 74, which means that professional investors are more optimistic about the stock than for 74% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 1, meaning that the share price of Penumbra is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 99% of alternative stocks in the same industry. ...read more

Country

USA

Industry Health Care Equipment

Size Medium

Website penumbrainc.com

Index

S&P MIDCAP

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.